Value in Health Regional Issues Paper of the Year Award

For the paper, “The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa,” Value in Health Regional Issue

For the paper, “Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia,” Value in Health Regional Issue

Value in Health Regional Issues (Asia pacific)

For the paper, “Current Status of Research on the Mapping Function of Health Utility Values in the Asia Pacific Region: A Systematic Review,” Value in Health Regional Issue

Value in Health Regional Issues (Central and Eastern Europe, Western Asia, and Africa)

For the paper, “Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies,” Value in Health Regional Issue

Value in Health Regional Issues (ASIA PACIFIC)

For the paper, “Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea,” Value in Health Regional Issues

Dr Syed Shahzad HASAN joined the University of Huddersfield in Sep 2017 and is currently working as a Senior Research Fellow in Pharmacy. He also holds a conjoint Senior Lecturer position at the University of Newcastle, Australia. Dr Hasan has taught a range of clinical pharmacy practice-related topics at universities in Malaysia (2007–2011 & 2015–2017), Australia (2012–2014 & 2018–to date), and the UK (2017–to date) and draws on experience as a pharmacist and researcher. His research focuses on pharmacoepidemiology, quality use of medicines, pharmaceutical policy and practice, medication safety & reviews, and evidence synthesis. Dr Hasan won a competitive, merit-based International Postgraduate Research Scholarship to complete a Doctor of Philosophy degree at the University of Queensland, Australia. Dr Hasan has published numerous research articles in leading health sciences journals, supervised many research students, and actively participates in the peer review process for several scientific journals.

Value in Health Regional Issues (Central and Eastern Europe, Western Asia, and Africa)

For the paper, “Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union,” Value in Health Regional Issues 2018;16:81-91.

Alexandra Beletsi, PharmD, PhD, has more than 15 years of commercial experience in pharmaceutical industry, with 10 years in the management team as Head of the Market Access Department and the last 3 years as the Head of the Medical Affairs Department in the Les Laboratoires Servier affiliate in Greece. In 1999, she received an MSc Degree in Industrial Pharmaceutics and in 2001 her PhD in Pharmaceutical Technology from University of Patras, Department of Pharmacy, Greece, having a Scholarship of the National Scholarship Foundation (IKY). In 2016, she received an MSc degree in Health Services Management, with a Direction of Economic Evaluation, from the National School of Public Health (ESDY), in Greece. Dr Beletsi’s main research interests include comparative health policy and healthcare reforms, and pharmaceutical economics, focusing in the pricing and reimbursement of medicines.

Value in Health Regional Issues (Latin America)

For the paper, “Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia,” Value in Health Regional Issues 2017;13:15-19.

José Miguel Uribe-Restrepo, MD, MPH, is an Associate Professor and Director of the Department of Psychiatry and Mental Health at Javeriana University Medical School and member of the Fundación Santa Fe de Bogotá. From 2004 to 2009, he was the Medical Director of the Clinica La Inmaculada in Bogotá, and during the last 25 years has practiced clinical psychiatry and psychotherapy both in private and public settings. Since 2006, he has been part of the GESESM group, an interdisciplinary collaboration for economic and social studies in mental health at Javeriana University. In 2013, he received his Master of Public Health at the Johns Hopkins Bloomberg School of Public Health. During the last 5 years, he has been part of collaborative research projects in Global Mental Health focusing on Colombia and is an expert consultant at Dartmouth College for the Scaling Up Science-based Mental Health Interventions for the Latin America implementation research project.

Value in Health Regional Issues (Asia)

For the paper, "Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea", Value in Health Regional Issues (2017); 12:7-9.

Value in Health Regional Issues (Latin America)

For the paper, "Cost-Effectiveness of a Care Program for HIV/AIDS Patients Affiliated with a Health Insurer in Colombia, Comparing Three Health Care Providers Nationwide," Value in Health Regional Issues (2016); 11:1-8.

Value in Health Regional Issues (Central and Eastern Europe, Western Asia, and Africa)

For the paper, "Cost Burden of Severe Community–Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review," Value in Health Regional Issues (2016); 10:53-60.

Following his graduation at the Technical University Munich, Ales Tichopad has been working for several research organization in various roles from Biostatistician, Health Economics Analyst to Managing Director. In 2008 Ales Tichopad co-founded CEEOR, the Central and Eastern European Outcomes Research organization that provided its worldwide customers with Real World Evidence and Market Access Services in the Central and Eastern Europe and on other predominantly emerging markets. Beside his role in CEEOR Ales Tichopad was active in academia, lecturing at Technical University Munich, Czech Technical University Prague and Czech Academy of Science. In 2015, CEEOR was acquired by Kantar Health.

Value in Health Regional Issues (Asia)

For the paper, "Burden of Disease Studies in the Asia-Paific Region: Are There Enough being Performed to Provide for Evidence-Based Health Policy?" (by Zhao, Gao, and Li), Value in Health Regional Issues (2013); 2:152-159.

Fei-Li Zhao, PhD, is a health economist with experiences gained from working in both academia and industry. Her research capacity and interests lie in economic evaluation using trial and real-world data, quality of life research and preference measurement, and health services research in Asia Pacific countries. Dr Zhao regularly undertakes research on behalf of the government and non-government agencies. This includes providing high quality, expert health technology assessment advice and support to the Pharmaceutical Benefits Advisory Committee (PBAC) for national reimbursement decision makings of pharmaceuticals and vaccines in Australia. She has presented nationally and internationally on her research and published series of papers on high-profile journals such as Value in Health, Pharmacoeconomics, PLOS One, Medical Care, Health Quality of Life Outcomes and BMC pregnancy and childbirth.

Value in Health Regional Issues (Latin America)

For the paper, "Societal Preferences for EQ-5D Health States from a Brazilian Population Survey," Value in Health Regional Issues 2013; 2:405-412.

Dr Andrade is an Associate Professor at the Economics Department at the Federal University of Minas Gerais, Belo Horizonte, Brazil. Dr Andrade works with applied microeconomics, specifically with health economics and evaluation of social programs. She received her PhD in Economics at the Graduate School of Getulio Vargas Foundation (1996 to 2000), Rio de Janeiro, and won the Award of best PhD dissertation, provided by the Associação Nacional de pós-Graduação em Economia, Haralambus Simonidis in 2000. In 2008-2009, she spent one year as a visiting researcher at Pompeu Fabra University, Center for Health Economics. At the Federal University of Minas Gerais, Monica is the leader of Health Economics Research Group, Grupo de Estudos em Economia da Saude e Criminalidade. The research group has carried out important investigations, including the estimation of social preferences for EQ-5D health states for Brazil. Monica was also the Dean of the Graduate Program of Economics during the period of 2003-2008. Monica is currently spending one year as a Takemi Fellow at Harvard School of Public Health, Global Health and Population Department. Monica is also a Researcher 1D of the National Council of Research (CNPQ) in Brazil and Member of the Committee (Economics) of the National Council of Research in Brazil.

Value in Health Regional Issues (Central and Eastern Europe, Western Asia, and Africa)

For the paper, “Impact of the Pharma-Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010),” Value in Health Regional Issues 2013; 2:290-299.

Rok Hren, PhD, has more than 15 years of commercial experience in pharmaceutical industry, with more than 10 years on a board level in both line management, which has included full P&L responsibility for operations in Slovenia and Romania, and regional leadership functions in Central and Eastern Europe. He regularly presents on the topic of pharmaceutical economics and policies at conferences in Europe and is well experienced in health care media business. Currently, he holds the position of a Managing Director of Carso, a Member of Salus Group PLC (SALR.SI). He received his PhD in Physiology and Biophysics from Dalhousie University, Canada and MSc in International Health Policy (Health Economics) with distinction from London School of Economics and Political Science, UK. He is also an Assistant Professor at the University of Ljubljana and a President of ISPOR Slovenia Regional Chapter. In total, his publications gathered 240/341citations (excluding self-citations) in WoS/Scopus (as of September 16, 2015).